Huang Y - Search Results

1

Predictive Value of High Preoperative Serum Total Protein and Elevated Hematocrit in Patients with Non-Small-Cell Lung Cancer after Radical Resection.

Cao J, Luo F, Zeng K, Ma W, Lu F, Huang Y, Zhang L, Zhao H. Cao J, et al. Among authors: huang y. Nutr Cancer. 2022;74(10):3533-3545. doi: 10.1080/01635581.2022.2079683. Epub 2022 Jun 1. Nutr Cancer. 2022. PMID: 35642624 Free article.

2

A large, single-center, real-world study of clinicopathological characteristics and treatment in advanced ALK-positive non-small-cell lung cancer.

Chen G, Chen X, Zhang Y, Yan F, Fang W, Yang Y, Hong S, Miao S, Wu M, Huang X, Luo Y, Zhou C, Gong R, Huang Y, Zhou N, Zhao H, Zhang L. Chen G, et al. Among authors: huang x, huang y. Cancer Med. 2017 May;6(5):953-961. doi: 10.1002/cam4.1059. Epub 2017 Apr 4. Cancer Med. 2017. PMID: 28374971 Free PMC article.

3

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis.

Zhou Y, Chen C, Zhang X, Fu S, Xue C, Ma Y, Fang W, Yang Y, Hou X, Huang Y, Zhao H, Hong S, Zhang L. Zhou Y, et al. Among authors: huang y. J Immunother Cancer. 2018 Dec 22;6(1):155. doi: 10.1186/s40425-018-0477-9. J Immunother Cancer. 2018. PMID: 30577837 Free PMC article.

4

Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients.

Zhou T, Zhao Y, Zhao S, Yang Y, Huang Y, Hou X, Zhao H, Zhang L. Zhou T, et al. Among authors: huang y. J Cancer. 2019 Apr 3;10(7):1685-1692. doi: 10.7150/jca.29319. eCollection 2019. J Cancer. 2019. PMID: 31205524 Free PMC article.

5

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706).

Zhang Z, Luo F, Zhang Y, Ma Y, Hong S, Yang Y, Fang W, Huang Y, Zhang L, Zhao H. Zhang Z, et al. Among authors: huang y. Cancer Commun (Lond). 2019 Nov 7;39(1):69. doi: 10.1186/s40880-019-0414-4. Cancer Commun (Lond). 2019. PMID: 31699150 Free PMC article.

6

Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis.

Zhou T, Zhang Z, Luo F, Zhao Y, Hou X, Liu T, Wang K, Zhao H, Huang Y, Zhang L. Zhou T, et al. Among authors: huang y. JAMA Netw Open. 2020 Oct 1;3(10):e2015748. doi: 10.1001/jamanetworkopen.2020.15748. JAMA Netw Open. 2020. PMID: 33074323 Free PMC article.

7

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.

Fang W, Jin H, Zhou H, Hong S, Ma Y, Zhang Y, Su X, Chen L, Yang Y, Xu S, Liao Y, He Y, Zhao H, Huang Y, Gao Z, Zhang L. Fang W, et al. Among authors: huang y. Mol Cancer. 2021 Feb 23;20(1):37. doi: 10.1186/s12943-021-01331-9. Mol Cancer. 2021. PMID: 33622313 Free PMC article. No abstract available.

8

Baseline and early changes in circulating Serum Amyloid A (SAA) predict survival outcomes in advanced non-small cell lung cancer patients treated with Anti-PD-1/PD-L1 monotherapy.

He LN, Fu S, Zhang X, Hu Q, Du W, Li H, Chen T, Chen C, Jiang Y, Zhou Y, Lin Z, Yang Y, Huang Y, Zhao H, Fang W, Zhang L, Hong S. He LN, et al. Among authors: huang y. Lung Cancer. 2021 Aug;158:1-8. doi: 10.1016/j.lungcan.2021.05.030. Epub 2021 May 28. Lung Cancer. 2021. PMID: 34087538

9

Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients.

Liu T, Zhou T, Luo F, Yang Y, Zhao S, Huang Y, Zhao H, Zhang L, Zhao Y. Liu T, et al. Among authors: huang y. Cancer Control. 2021 Jan-Dec;28:10732748211028257. doi: 10.1177/10732748211028257. Cancer Control. 2021. PMID: 34184581 Free PMC article.

10

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes.

Luo F, Cao J, Lu F, Zeng K, Ma W, Huang Y, Zhang L, Zhao H. Luo F, et al. Among authors: huang y. Cancer Cell Int. 2021 Aug 28;21(1):458. doi: 10.1186/s12935-021-02162-w. Cancer Cell Int. 2021. PMID: 34454491 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,158 results

Search Page

Filters